Selected article for: "blood concentration and human study"

Author: Bülow Anderberg, Sara; Lipcsey, Miklos; Hultström, Michael; Eriksson, Ann-Katrin; Venge, Per; Frithiof, Robert
Title: Systemic Human Neutrophil Lipocalin Associates with Severe Acute Kidney Injury in SARS-CoV-2 Pneumonia
  • Cord-id: maie5k02
  • Document date: 2021_9_14
  • ID: maie5k02
    Snippet: Neutrophils have been suggested mediators of organ dysfunction in COVID-19. The current study investigated if systemic neutrophil activity, estimated by human neutrophil lipocalin (HNL) concentration in peripheral blood, is associated with acute kidney injury (AKI) development. A total of 103 adult patients admitted to intensive care, with PCR-confirmed SARS-CoV-2 infection, were prospectively included (Clinical Trials ID: NCT04316884). HNL was analyzed in plasma (P-HNL Dimer) and in whole blood
    Document: Neutrophils have been suggested mediators of organ dysfunction in COVID-19. The current study investigated if systemic neutrophil activity, estimated by human neutrophil lipocalin (HNL) concentration in peripheral blood, is associated with acute kidney injury (AKI) development. A total of 103 adult patients admitted to intensive care, with PCR-confirmed SARS-CoV-2 infection, were prospectively included (Clinical Trials ID: NCT04316884). HNL was analyzed in plasma (P-HNL Dimer) and in whole blood (B-HNL). The latter after ex vivo activation with N-formyl-methionine-leucine-phenylalanine. All patients developed respiratory dysfunction and 62 (60%) were treated with invasive ventilation. Sixty-seven patients (65%) developed AKI, 18 (17%) progressed to AKI stage 3, and 14 (14%) were treated with continuous renal replacement therapy (CRRT). P-HNL Dimer was higher in patients with invasive ventilation, vasopressors, AKI, AKI stage 3, dialysis, and 30-day mortality (p < 0.001–0.046). B-HNL performed similarly with the exception of mild AKI and mortality (p < 0.001–0.004). The cohort was dichotomized by ROC estimated cutoff concentrations of 13.2 µg/L and 190 µg/L for P-HNL Dimer and B-HNL respectively. Increased cumulative risks for AKI, AKI stage 3, and death were observed if above the P-HNL cutoff and for AKI stage 3 if above the B-HNL cutoff. The relative risk of developing AKI stage 3 was nine and 39 times greater if above the cutoffs in plasma and whole blood, respectively, for CRRT eight times greater for both. In conclusion, systemically elevated neutrophil lipocalin, interpreted as increased neutrophil activity, was shown to be associated with an increased risk of severe AKI, renal replacement therapy, and mortality in COVID-19 patients with respiratory failure.

    Search related documents:
    Co phrase search for related documents
    • abbott laboratories and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
    • abbott park and acute respiratory syndrome: 1
    • abbott park and acute respiratory syndrome coronavirus: 1
    • activate neutrophil and acute ards respiratory distress syndrome: 1
    • activate neutrophil and acute respiratory syndrome: 1, 2
    • activate neutrophil and acute respiratory syndrome coronavirus: 1, 2
    • activate state and adaptive innate: 1
    • activation process and acute ards respiratory distress syndrome: 1
    • activation process and acute kidney injury: 1
    • activation process and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • activation process and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • active source and acute respiratory syndrome: 1, 2, 3, 4, 5
    • active source and acute respiratory syndrome coronavirus: 1, 2, 3, 4
    • acute aki kidney injury and adaptive innate: 1, 2, 3
    • acute aki kidney injury and adaptive innate immune response: 1, 2
    • acute aki kidney injury incidence and adaptive innate: 1
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adaptive innate immune response: 1, 2, 3, 4, 5, 6, 7
    • acute kidney injury and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8